Core Insights - NanoVibronix, Inc. will change its corporate name to ENvue Medical, Inc. effective December 12, 2025, to align with its strategic focus on the ENvue® feeding-tube placement system [1] - The company's stock ticker will change to "FEED" on the same date, with no action required from current stockholders [2] Company Strategy - The company aims to scale hospital utilization, enhance its commercial presence, and develop a comprehensive enteral-feeding ecosystem around ENvue through both internal and external opportunities [2] - The rebranding signifies a new phase characterized by precision enteral access, technology-driven growth, and clinical excellence [2] Company Overview - NanoVibronix, Inc. specializes in non-invasive and minimally invasive medical technology solutions, with headquarters in Tyler, Texas, and R&D in Nesher, Israel [3] - The company focuses on advancing standards in non-invasive therapy and minimally invasive navigation, emphasizing patient safety, clinical usability, and technological innovation [3] Product Information - The ENvue Navigation Platform is a minimally invasive electromagnetic navigation system designed to assist clinicians in placing feeding tubes, providing real-time visualization during the procedure [5] - The platform is FDA 510(k) cleared for adult use and may expand to include pediatric and vascular access applications in the future [5]
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'